Atossa Genetics Completes Sale of Its Wholly-Owned Subsidiary The National Reference Laboratory for Breast Health, Inc.
SEATTLE, WA -- (Marketwired) -- 12/17/15 -- Atossa Genetics Inc. (NASDAQ: ATOS), a healthcare company focused on developing locally-administered pharmaceuticals for the treatment of pre-cancerous conditions and early stage breast cancer, today announced …